ODDB.org: Open Drug Database

Venlafaxin-Mepha Teva 75 mg, Tabletten - 30 Tablette(n)

Swissmedic Key	60135002	Registration Holder	Mepha Pharma AG
Name	Venlafaxin-Mepha Teva 75 mg, Tabletten	Date of registration	15.04.2010
		Introduction of Sequence	15.04.2010
ATC-Classification	Venlafaxine (N06AX16)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	01.06.	Show package size	30 Tablette(n)
Index Therapeuticus (Swissmedic)	01.06.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680601350020	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

venlafaxinum 75 mg ut venlafaxini hydrochloridum, lactosum monohydricum 194.058 mg, silica colloidalis anhydrica, magnesii stearas, carboxymethylamylum natricum A corresp. natrium max. 0.630 mg, E 172 (flavum), E 172 (rubrum), pro compresso.

Packungsbestandteile

Galenic Form

Tablets

Active Agent	Dose
Venlafaxine	75 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Carboxymethylamylum Natricum A
E 172		color.
Lactose Monohydrate	194.058 mg
Magnesii Stearas
Pro Compresso
Silica Colloidalis Anhydrica

Source

Data was imported : 04.12.2014 Swissmedic Registration : 60135 Sequence : 02 Product name : Venlafaxin-Teva 75 mg, Tabletten Registration owner: : Teva Pharma AG Product group : Index Therapeuticus (BSV) : 01.06.0. Medication Code : Synthetika human Date of registration : 15.04.2010 Valid until : 14.04.2020 Package number : 002 Show package size : 30 Commercial Form/Unit : Tablette(n) Swissmedic categorie. : B Active Agents : venlafaxinum Composition : venlafaxinum 75 mg ut venlafaxini hydrochloridum, excipiens pro compresso.

2024	©ywesee GmbH